Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

864 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.
Ewers M, Mattsson N, Minthon L, Molinuevo JL, Antonell A, Popp J, Jessen F, Herukka SK, Soininen H, Maetzler W, Leyhe T, Bürger K, Taniguchi M, Urakami K, Lista S, Dubois B, Blennow K, Hampel H. Ewers M, et al. Among authors: hampel h. Alzheimers Dement. 2015 Nov;11(11):1306-15. doi: 10.1016/j.jalz.2014.12.006. Epub 2015 Mar 21. Alzheimers Dement. 2015. PMID: 25804998
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H. Buerger K, et al. Among authors: hampel h. Arch Neurol. 2002 Aug;59(8):1267-72. doi: 10.1001/archneur.59.8.1267. Arch Neurol. 2002. PMID: 12164722 Clinical Trial.
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
Bagli M, Papassotiropoulos A, Hampel H, Becker K, Jessen F, Bürger K, Ptok U, Rao ML, Möller HJ, Maier W, Heun R. Bagli M, et al. Among authors: hampel h. Eur Arch Psychiatry Clin Neurosci. 2003 Feb;253(1):44-8. doi: 10.1007/s00406-003-0405-x. Eur Arch Psychiatry Clin Neurosci. 2003. PMID: 12664314
Immunotherapy for Alzheimer's disease.
Dodel RC, Hampel H, Du Y. Dodel RC, et al. Among authors: hampel h. Lancet Neurol. 2003 Apr;2(4):215-20. doi: 10.1016/s1474-4422(03)00349-1. Lancet Neurol. 2003. PMID: 12849209 Review.
CSF markers for incipient Alzheimer's disease.
Blennow K, Hampel H. Blennow K, et al. Among authors: hampel h. Lancet Neurol. 2003 Oct;2(10):605-13. doi: 10.1016/s1474-4422(03)00530-1. Lancet Neurol. 2003. PMID: 14505582 Review.
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K. Hampel H, et al. Arch Gen Psychiatry. 2004 Jan;61(1):95-102. doi: 10.1001/archpsyc.61.1.95. Arch Gen Psychiatry. 2004. PMID: 14706948
864 results